Published by Josh White on 5th March 2024
(Sharecast News) - Cell engineering technology specialist MaxCyte said in an update on Tuesday that it expected total 2023 revenue of between $41.1m and $41.3m, down from $44.3m in 2022.
URL: http://www.digitallook.com/dl/news/story/34132971/...